Merck & Co., Inc. Noncontrolling Interest, Decrease from Deconsolidation
Merck & Co., Inc. (MRK) reported Noncontrolling Interest, Decrease from Deconsolidation of $75.00 million for the 12-month period ending 2015-12-31, per its 10-K filed 2017-02-28.
Discontinued › Shareholders' Equity › Noncontrolling Interest Items
us-gaap:NoncontrollingInterestDecreaseFromDeconsolidation · last filed 2017-02-28
- Merck & Co., Inc. noncontrolling interest, decrease from deconsolidation for the quarter ending 2015-12-31 was -$1.00M.
- Merck & Co., Inc. noncontrolling interest, decrease from deconsolidation for fiscal 2015 was $75.00M.
| Period end | Noncontrolling Interest, Decrease from Deconsolidation 3 month | Noncontrolling Interest, Decrease from Deconsolidation 9 month | Noncontrolling Interest, Decrease from Deconsolidation 12 month |
|---|---|---|---|
| 2015-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $75.00M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $76.00M 10-Q · filed 2016-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |